Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – 9,10-seco- cyclopentanohydrophenanthrene ring system doai
Reexamination Certificate
2007-03-06
2007-03-06
Pryor, Alton (Department: 1616)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
9,10-seco- cyclopentanohydrophenanthrene ring system doai
C514S944000, C514S947000, C424S449000
Reexamination Certificate
active
10278033
ABSTRACT:
The present invention provides compositions, methods, and kits for improving health in a woman having elevated SHBG levels, or who is receiving oral estrogen supplementation, by non-orally administering an effective amount of an androgenic steroid. Further, the present invention provides compositions, methods, and kits for coadministering an effective amount of an orally administered estrogen and an effective amount of a non-orally administered androgenic steroid for women in need of estrogen supplementation.
REFERENCES:
patent: 4849224 (1989-07-01), Chang et al.
patent: 4983395 (1991-01-01), Chang et al.
patent: 5122383 (1992-06-01), Heiber et al.
patent: 5152997 (1992-10-01), Ebert et al.
patent: 5460820 (1995-10-01), Ebert et al.
patent: 5550107 (1996-08-01), Labrie
patent: 5855920 (1999-01-01), Chein
patent: 5872114 (1999-02-01), Labric
patent: 5962021 (1999-10-01), Hughes, Jr. et al.
patent: WO 95/03764 (1995-02-01), None
patent: WO 97/03676 (1997-02-01), None
patent: WO 98/02167 (1998-01-01), None
U.S. Appl. No. 10/278,033, filed Aug. 1994, Pike et al.
Miller et al., Transdermal Testosterone Administration in Women with Acquired Immunodeficiency Syndrome Wasting: A Pilot Study, 1998, J. of Clin. Endocrin. and Metab., vol. 63 No. 8, pp. 2717-2719.
Dunn, et al., Transport of Steroid Hormones: Binding of 21 Endogenous Steroids to Both Testosterone-Binding Globulin and Corticosteroid-Binding Globulin in Human PlasmaJournal of Clinical Endocrinology and Metabolism, vol. 53:58-67 (1981).
Rosner et al., Sex Hormone-Binding Globulin Mediates Steroid Hormone Signal Transduction at the Plasma MembraneJ. Steroid Biochem. Mol. Biol. vol. 69:481-5 (1999).
Petra, P.H. The plasma Sex Steroid Binding Protein (SBP or SHBG). A Critical Review of Recent Developments on the Structure, Molecular Biology, and Function,J. Steroid Biochem. Mol. Biol., vol. 40:735-53 (1991).
Khan et al., Radioimmunoassay for Human Testosterone-Estradiol-Binding GlobulinJ. Clinical Endocrinology and Metabolism, vol. 54:705-710 (1982).
Bond et al., Sex Hormone Binding Globulin in Clinical Perspective,Acta. Obstet. Gynecol. Scand., vol. 66:255-262 (1987).
Miller, et al. Transdermal Testosterone Administration in Women with Acquired Immunodeficiency Syndrome Wasting: A Pilot Study,J. of Clinical Endocrinology and Metabolism, vol. 83:27172725 (1998).
Furuyama et al., Radioimmunoassay for Plasma Testosterone,Steroids. 1970;16:415-428 .
Vermeulen et al., A Critical Evaluation of Simple Methods for the Estimation of Free Testosterone in Serum,J. of Clinical Endocrinology and Metabolismvol. 84:3666-3672 (1999).
Nankin et al. Daytime Titers of Testosterone, LH, Estrone, Estradiol, and Testosterone-Binding Protein: Acute Effects of LH and LH-Releasing Hormone in Men,J. Clinical Endocrinology Metabolism, vol. 41:271-81 (1975.
Winters et al. The Analog Free Testosterone Assay: Are the Results in Men Clinically Useful?,Clinical Chemistryvol. 44:2178-2182 (1998); see also, Vermeulen et al. (1999).
Mathor et al., Free Plasma Testosterone Levels During the Normal Menstrual Cycle,J. Endocrinol Investvol. 8:437-41 (1985).
Brief Index of Sexual Functioning for Women, (Taylor et al 1994).
Derogatis Interview for Sexual Functioning, Derogatis, L., The Derogatis iInterview for Sexual Functioning (DISF/DISF-SR): and introductory report,J. Sex. Marital Ther. Winter 23(4):291-304 (1997).
Derogatis et al., Psychological assessment measures of human sexual functioning in clinical Trials,Int. J. Impot. Res., May 10 Suppl. 2:S13-20 (1998).
Beck Depression Inventory (Beck et al 1961).
Psychological General Well-being Index (Dupuy 1984).
Mathers et al. Menopause and Tear Function: The Influence of Prolactin and Sex Hormones on Human Tear Production,Corneavol. 17:353-8 (1998).
Vermeulen et al. Metabolic Clearance Rate and Interconversion of Androgens and the Influence of the Free Androgen FractionJ. Clinical Endocrinology and Metabolismvol. 48:320-326 (1979).
Longcope et al. Free Estradiol, Free Testosterone, and Sex Hormone-Binding Globulin in Perimenopausal Women,J. Clinical Endocrinology and MetabolismVo. 64:513-518 (1987).
Mazer Norman A.
Rosario-Jansen Theresa
Pryor Alton
Thorpe North & Western
Watson Pharmaceuticals, Inc.
LandOfFree
Administration of non-oral androgenic steroids to women does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Administration of non-oral androgenic steroids to women, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Administration of non-oral androgenic steroids to women will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3796326